Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 8Polycythemia Vera 6Multiple Myeloma 5Prostatic Neoplasms 4Neoplasms 4Colonic Neoplasms 4Cardiovascular Diseases 4Venous Thromboembolism 3Thrombocythemia, Essential 3Precancerous Conditions 3Ovarian Neoplasms 3Neoplasms, Plasma Cell 3Myeloproliferative Disorders 3Melanoma 3Esophageal Neoplasms 3Barrett Esophagus 3Tobacco Use Disorder 2Thrombosis 2Thromboembolism 2Stomach Neoplasms 2Rectal Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Adenomatous Polyps 2Vascular Diseases 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stroke 1

Interventions

Oxygen 2Indocyanine Green 2Diagnostic Imaging 2tislelizumab 1Tomography, X-Ray Computed 1Tomography 1Thoracic Surgery, Video-Assisted 1Positron-Emission Tomography 1Positron Emission Tomography Computed Tomography 1Oxycodone 1Nitrous Oxide 1Methylene Blue 1Fluoroscopy 1Fluorodeoxyglucose F18 1Carbon Dioxide 1Aspirin 14-(3-fluoropropyl)glutamic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Multiple Pulmonary Nodules × Aspirin × Clear all
NCT02169271 2020-05-21

Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules

National Cancer Institute (NCI)

Phase 2 Completed
109 enrolled 27 charts

Tobacco Use Disorder, Smoking Cessation, Multiple Pulmonary Nodules

Data powered by HemOnc (CC BY 4.0) Colophon âš¡